Verrica Pharmaceuticals Inc. VRCA Q1 2026 earnings

FAQ

When did Verrica Pharmaceuticals Inc. report Q1 2026 earnings?

Verrica Pharmaceuticals Inc. (VRCA) reported Q1 2026 earnings on May 12, 2026 after market close.

What were Verrica Pharmaceuticals Inc.'s Q1 2026 revenue and EPS?

Verrica Pharmaceuticals Inc. reported revenue of $5.0M and eps of $-0.41 for Q1 2026.

Did Verrica Pharmaceuticals Inc. beat estimates in Q1 2026?

Revenue beat the consensus estimate of $4.5M by $508.8K. EPS beat the consensus estimate of $-0.59 by $0.18.

How did Verrica Pharmaceuticals Inc.'s Q1 2026 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 46.1% from $3.4M a year earlier and eps grew 59.0% from $-1.00.

Where can I find Verrica Pharmaceuticals Inc.'s Q1 2026 SEC filings?

You can read the 8-K earnings release (0001193125-26-219395) and the 10-Q periodic report (0001660334-26-000014) directly on SEC EDGAR. The filing index links above go to sec.gov.